Literature DB >> 26213563

Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

Steven F Baker1, Aitor Nogales1, Luis Martínez-Sobrido1.   

Abstract

Vaccination represents the best option to protect humans against influenza virus. However, improving the effectiveness of current vaccines could better stifle the health burden caused by viral infection. Protein synthesis from individual genes can be downregulated by synthetically deoptimizing a gene's codon usage. With more rapid and affordable nucleotide synthesis, generating viruses that contain genes with deoptimized codons is now feasible. Attenuated, vaccine-candidate viruses can thus be engineered with hitherto uncharacterized properties. With eight gene segments, influenza A viruses with variably recoded genomes can produce a spectrum of attenuation that is contingent on the gene segment targeted and the number of codon changes. This review summarizes different targets and approaches to deoptimize influenza A virus codons for novel vaccine generation.

Entities:  

Keywords:  codon deoptimization; codon usage bias; codon-pair bias; inactivated influenza vaccines; influenza A virus; influenza reverse genetics; live attenuated influenza virus; recombinant influenza vaccine; synthetic attenuated virus engineering

Year:  2015        PMID: 26213563      PMCID: PMC4508661          DOI: 10.2217/fvl.15.31

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  94 in total

Review 1.  Evolution of synonymous codon usage in metazoans.

Authors:  Laurent Duret
Journal:  Curr Opin Genet Dev       Date:  2002-12       Impact factor: 5.578

2.  Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions.

Authors:  Yukiko Muramoto; Ayato Takada; Ken Fujii; Takeshi Noda; Kiyoko Iwatsuki-Horimoto; Shinji Watanabe; Taisuke Horimoto; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Codon bias as a factor in regulating expression via translation rate in the human genome.

Authors:  Yizhar Lavner; Daniel Kotlar
Journal:  Gene       Date:  2004-12-24       Impact factor: 3.688

Review 4.  Viruses and the type I interferon antiviral system: induction and evasion.

Authors:  Christopher F Basler; Adolfo García-Sastre
Journal:  Int Rev Immunol       Date:  2002 Jul-Oct       Impact factor: 5.311

5.  Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs.

Authors:  R Bullido; P Gómez-Puertas; M J Saiz; A Portela
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

Review 7.  Toward a universal influenza virus vaccine: prospects and challenges.

Authors:  Natalie Pica; Peter Palese
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

Review 8.  Attenuated influenza virus vaccines with modified NS1 proteins.

Authors:  Jüergen A Richt; Adolfo García-Sastre
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

9.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Authors:  Edward A Belongia; Burney A Kieke; James G Donahue; Robert T Greenlee; Amanda Balish; Angie Foust; Stephen Lindstrom; David K Shay
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

Review 10.  Conformational plasticity of the influenza A virus NS1 protein.

Authors:  Benjamin G Hale
Journal:  J Gen Virol       Date:  2014-06-13       Impact factor: 3.891

View more
  12 in total

1.  Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.

Authors:  Aitor Nogales; Laura Rodriguez; Caroline Chauché; Kai Huang; Emma C Reilly; David J Topham; Pablo R Murcia; Colin R Parrish; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

2.  Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Authors:  Hoai J Ly; Shoko Nishiyama; Nandadeva Lokugamage; Jennifer K Smith; Lihong Zhang; David Perez; Terry L Juelich; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Vaccine       Date:  2017-10-20       Impact factor: 3.641

3.  Comparative Analysis of Predicted Gene Expression among Crenarchaeal Genomes.

Authors:  Shibsankar Das; Brajadulal Chottopadhyay; Satyabrata Sahoo
Journal:  Genomics Inform       Date:  2017-03-29

4.  The Evolution of Molecular Compatibility between Bacteriophage ΦX174 and its Host.

Authors:  Alexander Kula; Joseph Saelens; Jennifer Cox; Alyxandria M Schubert; Michael Travisano; Catherine Putonti
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

Review 5.  Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.

Authors:  Luis Martínez-Sobrido; Olve Peersen; Aitor Nogales
Journal:  Viruses       Date:  2018-10-15       Impact factor: 5.048

Review 6.  Novel Approaches for The Development of Live Attenuated Influenza Vaccines.

Authors:  Pilar Blanco-Lobo; Aitor Nogales; Laura Rodríguez; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2019-02-22       Impact factor: 5.048

Review 7.  Host Single Nucleotide Polymorphisms Modulating Influenza A Virus Disease in Humans.

Authors:  Aitor Nogales; Marta L DeDiego
Journal:  Pathogens       Date:  2019-09-30

8.  A Hyper-Attenuated Variant of Rift Valley Fever Virus Generated by a Mutagenic Drug (Favipiravir) Unveils Potential Virulence Markers.

Authors:  Belén Borrego; Alejandro Brun
Journal:  Front Microbiol       Date:  2021-02-09       Impact factor: 5.640

9.  Characterization of codon usage pattern in SARS-CoV-2.

Authors:  Wei Hou
Journal:  Virol J       Date:  2020-09-14       Impact factor: 4.099

10.  A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.

Authors:  Jayanti Saha; Sukanya Bhattacharjee; Monalisha Pal Sarkar; Barnan Kumar Saha; Hriday Kumar Basak; Samarpita Adhikary; Vivek Roy; Parimal Mandal; Abhik Chatterjee; Ayon Pal
Journal:  Gene Rep       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.